The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntegraFin Holdings Regulatory News (IHP)

Share Price Information for IntegraFin Holdings (IHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.00
Bid: 306.00
Ask: 306.50
Change: 7.00 (2.34%)
Spread: 0.50 (0.163%)
Open: 300.00
High: 308.00
Low: 300.00
Prev. Close: 299.00
IHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Nucleus Financial Group plc

2 Dec 2020 17:35

RNS Number : 3441H
IntegraFin Holdings plc
02 December 2020
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

 

THIS IS AN ANNOUNCEMENT UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE AND THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER MIGHT BE MADE.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

 

FOR IMMEDIATE RELEASE

 

2 December 2020

IntegraFin Holdings plc

Statement Regarding Nucleus Financial Group plc

 

IntegraFin Holdings plc ("IntegraFin") notes the recent announcement by Nucleus Financial Group plc ("Nucleus").

 

As part of our strategic planning, we regularly consider potential acquisition opportunities. In the light of this, we are currently in the early stages of reviewing the strategic and financial merits of a possible acquisition of Nucleus. Any such offer, if made, is likely to be solely in cash although IntegraFin reserves the right to vary the form and / or mix of any consideration offered.

 

We have a high hurdle for taking opportunities forward. Therefore, there can be no certainty (i) that we will proceed with our discussions and make a formal offer to acquire Nucleus, nor (ii) as to the terms on which any offer might be made.

 

The Panel has confirmed to Nucleus that no deadline pursuant to Rule 2.6(a) of the Takeover Code will currently apply as a result of this announcement.

 

A further announcement will be made as and when appropriate.

 

LEI number: 213800CYIZKXK9PQYE87

Enquiries

 

IntegraFin +44 (0)20 7608 4900 Alex Scott, Chief Executive Officer

 

Lansons (PR Adviser to IntegraFin) Tony Langham +44 (0)79 7969 2287

integrafin@lansons.com

 

Evercore (Financial Adviser to IntegraFin) +44 (0)20 7653 6000 Ollie Clayton

Edward Banks

Demetris Efthymiou

 

 

In accordance with Rule 26.1 of the Code, a copy of this announcement will, subject to certain restrictions relating to persons resident in restricted jurisdictions, be available at www.integrafin.co.uk. For the avoidance of doubt, the content of the website referred to above is not incorporated into and does not form part of this announcement.

MAR

The information contained within this announcement is considered by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information will be considered to be in the public domain.

ABOUT EVERCORE

Evercore Partners International LLP ("Evercore"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as financial adviser exclusively to IntegraFin and no one else in connection with the matters described in this announcement and will not be responsible to anyone other than IntegraFin for providing the protections afforded to clients of Evercore nor for providing advice in connection with the matters referred to herein. Neither Evercore nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Evercore in connection with this announcement, any statement contained herein, any offer or otherwise. Apart from the responsibilities and liabilities, if any, which may be imposed on Evercore by the Financial Services and Markets Act 2000 and successor legislation, or the regulatory regime established thereunder, or under the regulatory regime of any jurisdiction where exclusion of liability under the relevant regulatory regime would be illegal, void or unenforceable, neither Evercore nor any of its affiliates accepts any responsibility or liability whatsoever for the contents of this announcement, and no representation, express or implied, is made by it, or purported to be made on its behalf, in relation to the contents of this announcement, including its accuracy, completeness or verification of any other statement made or purported to be made by it, or on its behalf, in connection with IntegraFin or the matters described in this announcement. To the fullest extent permitted by applicable law, Evercore and its affiliates accordingly disclaim all and any responsibility or liability whether arising in tort, contract or otherwise (save as referred to above) which they might otherwise have in respect of this announcement or any statement contained herein.

 

DISCLOSURE REQUIREMENTS OF THE CODE

Under Rule 8.3(a) of the Code, any person who is interested in 1 per cent. or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified.

An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by not later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by not later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1 per cent. or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by not later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4 of the Code).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OFDEAXAAEDAEFFA
Date   Source Headline
23rd Apr 20241:49 pmRNSDirector/PDMR Shareholding
16th Apr 20247:15 amRNS2nd Quarter Results
22nd Mar 20242:31 pmRNSDirector/PDMR Shareholding
12th Mar 20243:49 pmRNSHolding(s) in Company
7th Mar 20244:45 pmRNSHolding(s) in Company
1st Mar 20247:00 amRNSResult of AGM
22nd Feb 20244:21 pmRNSDirector/PDMR Shareholding
30th Jan 20249:31 amRNSDirector/PDMR Shareholding
23rd Jan 20243:27 pmRNSAnnual Report and Notice of AGM
23rd Jan 20241:24 pmRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNS1st Quarter Results
10th Jan 202412:50 pmRNSHolding(s) in Company
8th Jan 20243:33 pmRNSDirector/PDMR Shareholding
5th Jan 20244:10 pmRNSDirector/PDMR Shareholding
22nd Dec 202311:52 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSFinal Results
24th Nov 202312:26 pmRNSCFO – commencement date of appointment
22nd Nov 20233:01 pmRNSDirector/PDMR Shareholding
25th Oct 20231:10 pmRNSHolding(s) in Company
24th Oct 202311:35 amRNSDirector/PDMR Shareholding
17th Oct 202310:01 amRNSMajor Shareholding Notifications
17th Oct 20237:00 amRNS4th Quarter Results
22nd Sep 202310:33 amRNSDirector/PDMR Shareholding
23rd Aug 202312:09 pmRNSDirector/PDMR Shareholding
24th Jul 20235:47 pmRNSDirector/PDMR Shareholding
18th Jul 20237:00 amRNS3rd Quarter Results
7th Jul 20238:18 amRNSAppointment of Chief Financial Officer
3rd Jul 20232:09 pmRNSDirector/PDMR Shareholding
26th Jun 20235:34 pmRNSDirector/PDMR Shareholding
26th Jun 20232:50 pmRNSDirector/PDMR Shareholding - Replacement
22nd Jun 20232:03 pmRNSDirector/PDMR Shareholding
12th Jun 20234:41 pmRNSHolding(s) in Company
2nd Jun 20235:30 pmRNSHolding(s) in Company
2nd Jun 20235:23 pmRNSHolding(s) in Company
26th May 20237:00 amRNSHalf-year Report
23rd May 20235:25 pmRNSHolding(s) in Company
23rd May 202311:53 amRNSDirector/PDMR Shareholding
16th May 202312:25 pmRNSHolding(s) in Company
10th May 20233:26 pmRNSHolding(s) in Company
3rd May 20234:20 pmRNSHolding(s) in Company
25th Apr 202311:38 amRNSDirector/PDMR Shareholding
18th Apr 20237:00 amRNS2nd Quarter Results
28th Mar 20233:18 pmRNSDirector/PDMR Shareholding
23rd Mar 20233:32 pmRNSDirector/PDMR Shareholding
23rd Feb 20235:16 pmRNSResult of AGM
22nd Feb 202310:39 amRNSDirector/PDMR Shareholding
9th Feb 20234:16 pmRNSHolding(s) in Company
31st Jan 202311:45 amRNSDirector/PDMR Shareholding
24th Jan 20235:09 pmRNSDirector/PDMR Shareholding
20th Jan 20239:33 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.